November 27, 2009 (FinancialWire) — Heska Corp. (NASDAQ: HSKA), a provider of diagnostic and specialty products to the veterinary industry, has inked agreements with Roche Diagnostics Corp. for the supply of blood gas products and affiliated consumables for the veterinary market.

Heska sells advanced veterinary diagnostic and other specialty veterinary products. Heska’s offerings include diagnostic instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals.

Basel, Switzerland-based Roche has operations in both pharmaceuticals and diagnostics. Roche is a biotech company with medicines in oncology, virology, inflammation, metabolism and CNS. The company also offers in-vitro diagnostics, tissue-based cancer diagnostics and products for diabetes management.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.